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Abstract
Using RNAse protection, we have made quantitative measure-
ments of erythropoietin (EPO) mRNA in liver and kidneys of
developing rats (days 1-54), to determine the relative contribu-
tion of both organs to the total EPO mRNA, to monitor
changes which occur with development, and to compare the
hypoxia-induced accumulation of EPO mRNA with the
changes in serum EPO concentrations. To determine whether
developmental and organ-specific responsiveness is related to
the type of hypoxic stimulus, normobaric hypoxia was com-
pared with exposure to carbon monoxide (functional anemia).
Under both stimuli EPO mRNA concentration in liver was
maximal on day 7 and declined during development. In con-
trast, EPO mRNA concentration in kidney increased during
development from day 1 when it was 30-65% the hepatic con-
centration to day 54 when it was 12-fold higher than in liver.
When organ weight was considered the liver was found to con-
tain the majority of EPO mRNA in the first three to four weeks
of life, and although, in stimulated animals, the hepatic propor-
tion declined from 85-91% on day 1, it remained - 33% at day
54 and was similar for the two types of stimuli. When normal-
ized for body weight the sum of renal and hepatic EPO mRNA
in animals of a particular age was related linearly to serum
hormone concentrations. However, the slope of this regression
increased progressively with development, suggesting age-de-
pendent alterations in translational efficiency or EPO metabo-
lism. (J. Clin. Invest. 1992. 89:753-760.) Key words: RNase
protection radioimmunoassay * normobaric hypoxia * carbon
monoxide * bilateral nephrectomy
Introduction
Erythropoietin (EPO)' is a glycoprotein hormone that is pro-
duced in inverse relationship to blood oxygen content and de-
termines the rate ofred cell formation. The sites ofEPO produc-
tion were originally deduced from the results of organ ablation
studies and more recently from the distribution of EPO
mRNA. Although these studies have firmly established the
liver and the kidneys as production sites for EPO, discrepancies
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exist and the relative importance of each organ has not been
determined unequivocally.
Organ ablation studies have revealed that in adult animals
the increase in serum EPO levels in response to hypobaric hyp-
oxia is reduced by - 80-90% after bilateral nephrectomy (1-
3), the remaining EPO formation being abolished when
nephrectomy is combined with subtotal hepatectomy (4). In
fetal and neonatal animals, however, bilateral nephrectomy
was found to have little or no effect on EPO formation, whereas
hepatectomy almost completely prevented an increase in
serum EPO concentrations under hypoxia (5-8). From a grad-
ual change in the effect of nephrectomy and/or hepatectomy
on EPO formation during development it was inferred that in
sheep a shift ofEPO production from liver to kidney is initiated
during late gestation, with a hepatic contribution to EPO pro-
duction of 70% around birth (9). In rats, moreover, the kid-
neys appeared to play no or little role in EPO formation for up
to two weeks after birth, thereafter gradually gaining increasing
importance (2, 3, 10).
Detection of EPO mRNA by Northern blotting of extracts
from different organs confirmed liver and kidney as the sites of
EPO gene expression (I 1, 12). In adult animals the abundance
of EPO mRNA in kidneys was much higher than that in liver
(1 1, 12). Furthermore, in a recent study Koury et al. measured
EPO mRNA levels in pooled extracts of kidneys and livers
from developing normal and anemic mice using both Northern
blotting and RNAse protection assay (13). They found the pro-
portion ofEPO mRNA in the liver decreasing with age, but, in
contrast to what may be anticipated from the organ ablation
studies, they observed that the kidneys contain most EPO
mRNA soon after they become macroscopically identifiable,
i.e., during late gestation and all stages of postnatal develop-
ment.
Several possibilities could explain this apparent discrep-
ancy between the ablation studies and the quantitative analysis
of EPO mRNA with regard to the role of the liver in EPO
formation. Thus it is possible that EPO formation after
nephrectomy and/or hepatectomy may not accurately reflect
the situation in intact animals. Furthermore, the role of the
liver for EPO formation may be species specific and be of less
importance in mice than in rats, goats, or sheep, or may depend
on the kind of stimulus used and be less significant in anemia
than in hypoxic hypoxia. Alternatively, the findings may indi-
cate that the relationship between EPO production rates and
EPO mRNA content varies between liver and kidney, i.e., that
hepatic EPO mRNA is more efficiently translated than renal
EPO mRNA.
The respective ability of liver and kidneys to produce EPO
and the responsiveness of both organs to different stimuli ap-
pears ofmajor importance not only for the regulation of eryth-
ropoiesis around birth, but may also have implications for EPO
formation under conditions of compromised kidney function
as in chronic renal disease. We have therefore addressed the
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above possibilities by studying the age dependence ofEPO gene
expression in rat kidneys and liver under basal conditions and
following the exposure to normobaric (hypoxic) hypoxia and
carbon monoxide (functional anemia). Both stimuli were ap-
plied for a short period offour hours to allow measurements at
precisely timed and closely spaced points during the early post-
natal phase and to avoid possible confounding effects from
adaptive processes which have been observed with more pro-
longed exposure to hypoxic hypoxia (14, 15). To investigate if
the duration of stimulation is of central importance in deter-
mining organ-specific responsiveness, additional experiments
were performed on adult animals studied after three days of
repetitive bleeding. The rat was chosen as experimental animal
to enable a direct comparison with the evidence available from
organ ablation studies. To further judge the significance of
these organ ablation studies for EPO formation in the intact
organism, we have also investigated the effect of nephrectomy
on hepatic EPO gene expression. To allow a direct comparison
between circulating EPO levels and EPO mRNA, serum EPO
levels were determined by radioimmunoassay and EPO
mRNA concentration was measured in kidneys and liver
from individual animals using a quantitative RNAse protec-
tion assay.
Methods
Animals. ZUR: SIV strain rats of different ages were bred in the local
animal house. Experiments were performed at ages 1 d, 7 d, 14 d, 28 d,
and 54 d postnatally. At ages 1, 7, and 14 d rats were kept together with
their mother until immediately before the experiment. After the sex of
the animals became identifiable, i.e., after 14 d, male animals were used
only.
Stimulation ofEPO production. For study of the age-dependent
changes ofEPO gene expression normobaric hypoxic hypoxia or func-
tional anemia caused by carbon monoxide inhalation were used to
stimulate EPO formation. Animals were exposed to these stimuli for 4
h in chambers that were gassed with a mixture ofnormal air and nitro-
gen or normal air with added carbon monoxide (0.1%). During hypoxic
hypoxia oxygen was gradually washed out of the chambers, reproduci-
bly reaching a concentration of 11% after 1 h and a concentration of
8.5% after 4 h, as determined by means of a fyrite oxygen indicator
(Bacharach Inc., Pittsburgh, PA). Litter mates of the animals exposed
to hypoxia were kept at normoxia and used for study ofEPO formation
under basal conditions.
Experiments with anemic animals. For study of the effect of more
prolonged stimulation on EPO gene expression adult rats (6-7 wk old)
were phlebotomized on three consecutive days. Under brief anesthesia
with fenatyl citrate and fluanisone animals were bled - 6.5, 5.5, and 5
ml from femoral veins on days 1-3, respectively, using saline for vol-
ume replacement.
Experiments with nephrectomized animals. Bilateral nephrecto-
mies were carried out in adult rats (6-7 wk old) under light methofane
anesthesia through bilateral flank incisions. 7 h after the operation
nephrectomized rats were exposed for 4 h to 0.1% carbon monoxide
together with sham-operated control animals.
24 h after the last phlebotomy (anemic animals), within 15 min after
the end ofcarbon monoxide exposure, and within 30 min after the end
of hypoxic hypoxia, animals were killed by decapitation (age 1-14 d)
followed by direct collection of blood or by cervical dislocation (age
28-54 d), after which blood was collected from the abdominal aorta.
Kidneys and livers were removed and after determination of wet
weight kidneys were completely and livers were in part or completely
homogenized in guanidine thiocyanate (4 M) containing sarcosyl
(0.5%), EDTA (10 mM), sodium citrate (25 mM), and mercaptoeth-
anol (700 mM). Different amounts ofguanidine thiocyanate were used
to maintain a constant concentration of - 0.04 g tissue per ml; except
for the kidneys of l-d old animals, when the concentration was 0.02 g
tissue per ml. After several determinations in earlier experiments dem-
onstrated that the concentration ofEPO mRNA is the same in all lobes
of the liver (16), weighed portions of the right lateral lobe were used in
those experiments where only a portion of the liver was homogenized.
Tissue homogenates were frozen at -80'C until preparation of RNA.
RNAse protection assay. RNAse protection assay was performed as
described (17). RNA was purified by centrifugation for 20 h at 33,000
rpm on a cesium chloride gradient (5.7 M CsCl and 100 mM EDTA).
After centrifugation RNA pellets were resuspended in 300 UI TE (10
mM Tris, 1 mM EDTA) containing 0.1% SDS, precipitated with 3 M
sodium acetate (0.1 vol) and ethanol (3 vol), and stored at -800C
before analysis.
The rat EPO probe was a PstI/SacI fragment containing 132 bp of
exon V and - 300 bp ofthe adjoining intron, inserted into pSP 64 for
generation ofRNA transcripts. Transcripts were continuously labelled
with alpha 32P-GTP (410 Ci/mmol; Amersham International, Amer-
sham, Bucks., UK). For hybridization aliquots of total RNA were dis-
solved in buffer (80% formamide, 40mM piperazine-N,N-bis(2-ethane
sulfonic acid), 400 mM sodium chloride, 1 mM EDTA pH 8) and the
RNA concentrations determined by measurement of optical density at
260 nm. The concentration was adjusted to yield 50-,ul samples con-
taining 100-150 ,g total RNA.
Hybridization was performed overnight at 60°C with 0.5-1.0 X 106
cpm radiolabelled EPO probe. RNAse digestion with RNAse A and TI
was carried out at 20°C for 30 min and terminated by the addition of
proteinase K and SDS before purification ofthe protected fragments by
phenol/chloroform extraction and ethanol precipitation and electro-
phoresis on a denaturing 10% polyacrylamide gel.
Autoradiography of the dried gel was performed at -70°C. Pro-
tected EPO mRNA bands were excised from the dried gel and counting
was performed using a flat-bed liquid scintillation counter (1205; Beta-
plater', Pharmacia-Wallac OY, Turku, Finland). The number of
counts per minute obtained from each EPO mRNA sample was di-
vided by the quantity of total RNA analyzed to yield the EPO mRNA
abundance (EPO mRNA/,ug total RNA). An external standard, con-
sisting of pooled RNA extracted from the kidneys of severely anemic
rats, was used to correct for any difference in quantitation arising be-
tween assays. 20,ug ofthe standard was run with each assay and sample
EPO mRNA levels were expressed relative to the EPO mRNA count in
the corresponding standard, which was assigned an arbitrary value of
1.0. In earlier experiments the results of duplicate RNAse protection
assays ofRNA prepared from the same organ showed a high degree of
reproducibility and assays ofdifferent concentrations ofRNA prepared
from the same organ exhibited linearity ofthe assay overthe experimen-
tal range (18).
The total organ quantity ofRNA in kidney and liver was calculated
from the amount of RNA extracted from aliquots of homogenate de-
rived from known weights of tissue. There was a reproducible linear
relationship between the RNA yield and the weight of tissue homoge-
nized.
EPO radioimmunoassay. Serum EPO concentrations were deter-
mined as described (19) with the use of a rabbit antiserum raised
against pure recombinant human EPO and iodinated recombinant hu-
man EPO (Amersham) as tracer. A rat serum pool enriched in EPO was
prepared by exposing donor animals to hypoxia and was used as stan-
dard after calibration against the II. International Reference Prepara-
tion by in vivo bioassay (19). Student's unpaired t test was used for
comparison of groups and analysis of variance to determine signifi-
cance levels of linear regressions. P < 0.05 was considered significant.
Results
Body weight, kidney, and liver weight ofthe animals studied at
different ages, the amount of total RNA extracted per gram
tissue, and the estimates of the amount of total RNA in both
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organs are given in Table I. In both liver and kidneys the con-
centrations of total RNA declined slightly during development
and at day 54 were 42% lower in liver and 36% lower in kidney
than in neonatal animals. At each age level the amount of total
RNA per gram tissue was about 2-fold higher in liver than in
kidney, and considering the differences in organ weight, the
liver contained approximately 5- to 8-fold more total RNA
than both kidneys during the first three weeks and approxi-
mately 10-fold more on days 28 and 54.
Measurements ofserum erythropoietin concentrations. The
serum EPO levels at the different ages under basal conditions
and after exposure to normobaric hypoxia or carbon monoxide
are given in Fig. 1. Under basal conditions EPO levels were
maximal one day after birth (62.6±19.2 mU/ml, mean±SE, n
= 7) and thereafter declined about 3-fold to reach a level two
weeks after birth that was similar to that of adults (17.7±5.5
mU/ml, mean±SE, n = 3). At all ages animals responded to
both stimuli with an increase in EPO levels. The amplitude of
this increase, however, was clearly age dependent, with 1.6-fold
and 2.1-fold increases in newborn animals and 12-fold and
87-fold elevations in adults. Consequently the absolute levels
of serum EPO were 2- and 12-fold higher in adult than in 4-d
old animals (208±55 versus 98.1 ± 12.7 for normobaric hypoxia
and 1,543±141 versus 133.8±28.3 for carbon monoxide stimu-
lation, respectively; mean±SE, n = 8 [newborn animals] or 3
[adult animals]).
Measurements oferythropoietin mRNA. To assess the accu-
mulation of EPO mRNA underlying these age- and stimulus-
dependent variations in serum EPO concentrations, EPO
mRNA in kidney and liver tissue of each animal was deter-
mined by RNAse protection assay. For quantitative analysis
the abundance of EPO mRNA in each sample (EPO mRNA
per ,ug total RNA) was calculated from the radioactivity of
protected fragments, and the value expressed relative to the
EPO mRNA count of an external standard that was run on
each gel. Figs. 2 and 3 show examples of autoradiographs ob-
tained with RNA from livers and kidneys of rats at different
stages of development. The mean values of the relative abun-
dance of EPO mRNA in liver and kidneys of all animals are
given in Fig. 4A. Since the concentration of total RNA in liver
and kidney is different and changes with age, the responsive-
ness ofEPO gene expression in liver and kidney tissue is more
clearly represented when EPO mRNA is related to tissue
weight. Accordingly, measurements ofthe concentration ofto-
tal RNA in each organ were used to calculate the concentration
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Figure 1. Serum immunoreactive EPO (irEPO) levels in developing
rats under unstimulated conditions (.), after 4 h of normobaric hyp-
oxia (A), and after 4 h of carbon monoxide exposure (m) (mean±SE,
n = 7-8 for 4-d old animals, 6 for 74 old animals exposed to carbon
monoxide, and 3 for all other groups). *Significant difference from
unstimulated controls.
of EPO mRNA per gram wet weight of tissue. In addition,
organ weights were used to calculate the total EPO mRNA in
each organ.
Table II shows the mean values ofEPO mRNA concentra-
tions per gram tissue weight at different ages in stimulated and
unstimulated rats. Under basal conditions the EPO mRNA
concentration on day 1 was eightfold higher in liver than in
kidney. Whereas in liver the basal EPO mRNA concentration
Table I. Body Weight and Weight and Total RNA Content ofLiver and Kidneys during Development
Liver Kidneys
Total RNA/ Total organ Total RNA/ Total organ
Age Body weight Organ weight gram tissue RNA Organ weight gram tissue RNA
days g mg g mg
1 (n = 23) 7.8±0.6 0.30±0.03 6.53±1.18 1.92±0.31 0.10±0.01 2.63±0.39 0.25±0.05
7 (n = 12) 15.7±2.3 0.46±0.08 5.76±1.40 2.70±0.98 0.21±0.03 2.84±0.58 0.59±0.17
14 (n = 9) 35.1±2.2 1.01±0.09 4.79±0.35 4.84±0.27 0.36±0.04 2.17±0.20 0.79±0.10
28 (n = 9) 93.4±12.4 4.51±0.77 4.54±0.77 20.4±3.9 1.03±0.13 1.95±0.17 2.00±0.18
54 (n = 9) 227.7±11.2 10.2±0.9 3.77±0.79 38.0±7.2 2.03±0.18 1.68±0.25 3.40±0.50
Mean±SD.
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Figure 2. Autoradiograph, after 6-d expo-
sure, of an RNase protection assay ofEPO
mRNA in the livers of rats under unstimu-
lated conditions, after 4 h ofnormobaric
hypoxia or exposure to carbon monoxide.
150 ,g oftotal RNA extracted from livers
of individual animals was analyzed by
RNAse protection after hybridization to a
32P-labelled transcript complementary to
132 bp of exon V and 300 bp of the ad-
joining intron of the rat EPO gene. Note
that EPO mRNA signals in livers are max-
imal on day 1 (unstimulated conditions)
or day 7 (normobaric hypoxia and carbon
monoxide) and thereafter decline progres-
sively with increasing age.
declined rapidly and was below the quantifiable range by day
28, in kidney the basal EPO mRNA concentration declined
fivefold within the first week and thereafter remained within
the quantifiable range and varied only slightly. After stimula-
tion EPO mRNA concentration increased in both organs at all
ages but the amplitude of the increase and the level attained at
different stages ofdevelopment was quite different between the
two organs. Under normobaric hypoxia and after exposure to
carbon monoxide the renal EPO mRNA concentration
achieved increased progressively with age, with the exception
only of a slight decline in 7-d-old animals exposed to normo-
baric hypoxia, so that by day 54 it was three- and sevenfold
higher than in neonates. In contrast the concentration ofEPO
mRNA achieved in liver tissue in response to both stimuli
showed little change between days 1 and 14 but thereafter de-
creased progressively so that by day 54 the hepatic EPOmRNA
concentration was 10-fold less than that in kidney for each
stimulus. When comparing the mean increases of renal and
hepatic EPO mRNA concentrations after stimulation, it be-
comes apparent that the response of EPO mRNA concentra-
tion to stimulation by exposure to carbon monoxide was al-
ways greater than by exposure to normobaric hypoxia, but the
difference generally became more marked with increasing age.
However, with the exception of 7-d old animals, in each age
group the relative efficacy of exposure to carbon monoxide
versus exposure to normobaric hypoxia was similar between
liver and kidneys.
The total amount ofEPO mRNA in liver and kidneys and
the relative contribution of the liver to EPO formation in the
whole animal are shown in Fig. 4 B and Table III. It can be seen
that the liver accounts for a remarkably large proportion ofthe
total EPO mRNA and contains the majority of EPO mRNA
for the first three to four weeks in both stimulated and unstim-
ulated rats. During this period, however, the predominance of
the liver was most pronounced under basal conditions. Thus
the liver accounts for more than 94% of EPO mRNA in un-
stimulated animals during the first three weeks, whereas under
normobaric hypoxia and carbon monoxide, the hepatic contri-
unstimulated
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Figure 3. Autoradiograph, after 14-h expo-
sure, of an RNAse protection assay ofEPO
mRNA in the kidneys of rats under unstim-
ulated conditions, after 4 h ofnormobaric
hypoxia or exposure to carbon monoxide.
150l g of total RNA from unstimulated
animals and animals exposed to normo-
baric hypoxia was assayed and 100 ug of
total RNA from animals exposed to carbon
monoxide. Inset shows signals of protected
fragments in unstimulated animals after
7-d exposure of the autoradiograph. While
the abundance ofEPO mRNA decreased
with age in kidneys of unstimulated ani-
mals, under stimulation EPO mRNA sig-
nals generally increased with age.
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bution was 91% and 85% in neonates. Although this propor-
tion decreased with age under both stimuli, at day 54 the liver
still contained on average 32 and 33% ofthe total EPO mRNA.
This hepatic contribution of about one-third in adult ani-
mals is considerably higher than that which has been previ-
ously measured in anemic mice (13) or has been inferred from
studies in bilaterally nephrectomized animals (1-3). Addi-
tional experiments were therefore performed to investigate if
EPO gene expression in rat liver under the above short-term
stimulation (a) differs from that during prolonged reductions
*
*
Figure 4. Changes with development in the
abundance ofEPO mRNA (A) and the to-
tal amount of EPO mRNA (B) in rat kid-
neys (closed symbols) and livers (open sym-
bols). EPO mRNA was quantified by scin-
tillation counting of protected EPO mRNA
bands and is expressed as EPO mRNA
counts minus background counts per mi-
crogram ofRNA loaded, divided by stan-
dard counts in each gel (Xl 0-4) (see Meth-
ods). Values are mean±SD, numbers of
animals as given in the legend of Fig. 1;
n.q., not quantifiable. *In (A) indicates sig-
nificant difference from the abundance of
EPO mRNA in unstimulated animals and
54 in (B) indicates significant difference be-
tween the total amount of EPO mRNA in
kidney and liver.
atocrit and (b) differs from that in acutely nephrecto-
animals. For this purpose separate groups of adult rats
;udied after induction of anemia by repetitive phlebot-id after exposure to carbon monoxide (0.1%) after bilat-
phrectomy.
7eriments with anemic animals. Repetitive phleboto-
three consecutive days (days 1-3) resulted in a decrease
atocrit values from 40.4±3.3% to 23.4±0.6%, 16.4±2%
±1% on days 2-4, and a corresponding increase in
EPO values from 16±1.6 mU/ml to 385±112 mU/ml,
Table II. Renal and Hepatic EPO mRNA Concentrations (EPO mRNA/g Tissue) during Development
Normobaric hypoxia Carbon monoxide
Relative increase
(1. 1-fold) 14.00±8.67
(2.7-fold) 20.30±13.23
(6.1-fold) 19.80±1.52
11.95±0.13
6.04±0.28
Unstimulated Normobaric hypoxia
Relative increase Relative increase
(1.8-fold) 1.00±0.92 2.78±1.79 (2.8-fold)(6.1-fold) 0.19±0.08 1.49±0.30 (7.8-fold)(15.7-fold) 0.25±0.14 7.05±1.83 (28.2-fold)
0.36±0.15 7.97±4.39 (22.1-fold)
0.18±0.06 8.92±1.46 (49.6-fold)
EPO mRNA was quantified by scintillation counting of protected fagments in RNAse protection assays and related to an external standard (seeFig. 4 and Methods). EPO mRNA concentrations per gram wet weight of tissue were calculated from the abundance ofEPO mRNA per gramof total RNA (Fig. 4 A) and the concentrations of total RNA per gram wet weight of tissue (Table I). mean±SD, n = 7-8 for 4-d old animals, 6for 74 old animals exposed to carbon monoxide, and 3 for all other groups. nq, not quantifiable.
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1 7.96±7.27
7 3.33±0.91
14 1.26±0.39
28 nq
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9.10±4.16
9.04±2.33
7.71±2.73
2.00±0.84
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Table III. Total Amount ofEPO mRNA (Sum ofRenal and Hepatic EPO mRNA) and Proportion of
Hepatic EPO mRNA during Development
Unstimulated Normobaric hypoxia Carbon monoxide
Hepatic Hepatic Hepatic
Total EPO mRNA/ Total EPO mRNA/ Total EPO mRNA/
Total EPO mRNA/ total Total EPO mRNA/ total Total EPOmRNA total
Age EPO mRNA body weight EPO mRNA EPO mRNA body weight EPO mRNA EPO mRNA body weight EPO mRNA
days rf % r % 8 %
1 2.41±2.19 0.322±0.30 95±3.2 3.01±1.24 0.371±0.15 91±5.1 4.77±2.74 0.616±0.39 85±10
7 1.72±0.66 0.133±0.05 98±0.5 3.76±0.83 0.289±0.10 93±1.4 18.57±12.89 1.021±0.69 64±18
14 1.44±0.52 0.041±0.02 94±1.2 9.75±2.17 0.284±0.08 73±9.1 30.02±6.88 0.351±0.19 69±11
28 0.34±0.14 0.004±0.00 17.99±5.80 0.189±0.07 55±16 141.4±19.71 1.548±0.03 35±2.4
54 0.34±0.11 0.001±0.00 29.28±6.77 0.140±0.07 32±12 182.1±32.62 0.818±0.14 33±3.9
Mean±SD; n = 7-8 for l-d old animals, 6 for 7-d old animals exposed to carbon monoxide, and 3 for all other groups.
1,278+511 mU/ml and 2,631±362 mU/ml, respectively
(mean±SD, n = 5). The total organ EPO mRNA on day 4 was
157.7±42.8 in kidneys and 80.9±32.8 in livers (mean±SD); the
resulting proportion of hepatic EPO mRNA in relation to the
total EPOmRNA was 34.4±11.5% (mean±SD) and not signifi-
cantly different from that following short-term exposure to hyp-
oxic hypoxia or carbon monoxide.
Experiments with nephrectomized animals. The amount of
EPO mRNA and serum EPO levels in adult rats exposed to
carbon monoxide 7 h after bilateral nephrectomy are shown in
Fig. 5. It can be seen that the serum EPO levels reached were
only 17% ofthose reached in the sham-operated controls. How-
ever, hepatic EPO mRNA accumulation in the liver of
nephrectomized animals was also significantly reduced to
- 55% of that observed in the sham-operated controls.
Relationship oferythropoietin mRNA to serum erythropoie-
tin concentrations during development. To facilitate compari-
son of EPO mRNA content with serum EPO concentration,
the total EPO mRNA content (the sum of renal and hepatic
EPOmRNA content) for stimulated and unstimulated animals
at different ages was normalized to the body weight (Table III).
When expressed in this way, the total EPO mRNA in animals
of a particular age was related linearly to the serum EPO con-
centration. This relationship was seen over a wide range of
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stimulated values irrespective of whether stimulation was by
normobaric hypoxia or by exposure to carbon monoxide, as
shown in Fig. 6. However, the slope of the regression was not
the same for each age group and increased progressively during
development, being approximately ninefold greater in 54-d-old
animals than in 1-d old animals. Thus, when normalized for
body weight, the total EPO mRNA content achieved under the
most powerful stimulus was approximately constant with devel-
opment (Table III), whereas the corresponding serum EPO lev-
els increased markedly (Fig. 1).
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Figure 5. EPO mRNA (A) and serum immunoreactive EPO (ir EPO)
(B) in rats exposed to carbon monoxide 7 h after bilateral nephrec-
tomy (NTX) (n = 7) and in sham-operated controls (n = 7). (A) dark
shadowing illustrates EPO mRNA in livers and light shadowing EPO
mRNA in kidneys ofcontrol animals. Quantitation ofEPO mRNA
as in Fig. 4. *Significant difference in the amount of hepatic EPO
mRNA (A) and serum hormone levels (B).
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Figure 6. Relationship between the total amount of EPO mRNA in
the animals, i.e., the sum of renal and hepatic EPO mRNA, normal-
ized for body weight and the serum immunoreactive EPO (ir EPO)
concentrations. At each age level serum hormone levels correlated
linearly with EPO mRNA (day 1: P < 0.0001, r: 0.86; day 7: P <
0.0001, r2: 0.89; day 14: P < 0.002, r2: 0.77; day 28: P < 0.0001, r9:
1.00; day 54: P < 0.0001, r2: 0.93). Individual values are included
only for the youngest (o) and oldest animals (o) investigated.
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Discussion
A major control mechanism for EPO formation has been
found to operate by modulation of EPO mRNA (1 1, 12, 20)
and this investigation demonstrates significant alterations in
the amount of EPO mRNA in rat kidneys and liver during
development, which is basically in accordance with the age
dependence ofthe effects ofbilateral nephrectomy and hepatec-
tomy on EPO formation (2, 5, 6, 10). In contrast to anemic
mice, as recently shown by Koury et al. (13), in the present
study the hepatic proportion ofEPO mRNA was considerable,
accounting for the majority ofEPO mRNA during early post-
natal life and for about one-third ofEPO mRNA during adult-
hood (Fig. 4 B, Table III). The predominance of the liver in
neonatal and juvenile animals was found irrespective of
whether the animals were stimulated or not and regardless of
whether the stimulus was normobaric hypoxia or exposure to
carbon monoxide. Irrespective of changes with age the hepatic
proportion of the total EPO mRNA was in fact very similar
under these two stimuli at 1, 14, and 54 days, and somewhat
lower only at 7 and 28 days in the carbon monoxide group
(Table III). Furthermore, although these stimuli were applied
for a short time only, the liver appears not to respond primarily
in the early phase of hypoxia, since the hepatic contribution
was also about one-third in adult animals with more prolonged
reductions in hematocrit. Thus, despite the differences in the
mode of limitation of oxygen delivery during normobaric hyp-
oxia, exposure to carbon monoxide, or anemia, there was no
striking difference between the relative sensitivity of liver and
kidney to each stimulus and under all conditions tested the
liver accounted for a surprisingly high proportion of the total.
Clearly, however, all stimuli were relatively severe, so that our
results may demonstrate the potential for hepatic gene expres-
sion rather than what is achieved under less severe stimulation.
For a given stimulus, there was a continuous decline ofthe
proportion of hepatic EPO mRNA with increasing age, result-
ing in a "shift" of the predominance from liver to kidneys
between three and four weeks. This shift was not due to a re-
duction in the total amount of EPO mRNA in the liver, but
rather resulted from a greater increase in the total amount of
EPO mRNA in the kidneys (Fig. 4 B). When organ weight is
taken into consideration, it is evident that the concentration of
EPO mRNA per gram liver tissue decreased with increasing age
of the animals, whereas the converse was true for renal EPO
mRNA concentrations (Table II). Recently, EPO gene expres-
sion was demonstrated by in situ hybridization in parenchymal
as well as nonparenchymal murine liver cells (21). However,
the type and size ofthe hepatic cell populations producing EPO
at different stages ofdevelopment are yet unknown. Ifthe num-
ber of hepatic EPO-producing cells increases in proportion to
liver growth, than the results suggest that for a given stimulus
these cells produce progressively less EPO after about two
weeks of life (Table II). Alternatively, the findings may indicate
that subpopulations of hepatic cells that produce EPO prolifer-
ate less rapidly than the majority of liver cells. In the kidneys
EPO mRNA increased out of proportion to the increase in
organ weight during development (Table II). Interestingly, in
this regard, in adult mice with varying degrees of anemia, the
modulation of EPO mRNA has been shown to reflect varia-
tions in the number of cells in the renal cortical interstitium
that express the EPO gene, with individual cells expressing the
gene in an essentially all-or-none manner (22). Whether the
age-dependent increase in EPO mRNA also results from an
increasing recruitment of cells remains to be investigated.
When considering the significance of the accumulation of
EPO mRNA, an important question arises with regard to the
efficiency with which EPO mRNA in liver and kidneys is trans-
lated to achieve a rise in serum hormone concentrations under
different stimuli and at different stages of development. If one
assumes that the distribution volume for EPO, that has been
shown in adult rats to correspond to plasma volume (23), is
proportional to body weight, it appears justifiable to compare
serum EPO levels with the total amount of EPO mRNA, i.e.,
the sum of renal and hepatic EPO mRNA, after it has been
normalized by body weight. At each age level, this comparison
revealed significant linear relationships (Fig. 6), a result in
keeping with the view that mRNA accumulation is the major
control mechanism ofEPO formation. Interestingly, however,
the slope of this relationship increases about ninefold during
development. Thus serum EPO levels at a given stimulus in-
creased with age (Fig. 1), an observation in accordance with
previous studies (2, 5, 10, 24, 25), although the total amount of
EPO mRNA when normalized for body weight was either con-
stant or even declined with age (Table III).
This age-dependent change in the relationship between
EPO mRNA and the circulating hormone concentrations
could arise by several mechanisms which the present study
cannot clearly differentiate. Age-dependent alterations in both
EPO production and metabolism, e.g., a decrease in distribu-
tion volume or clearance rate of the hormone are possible.
With regard to EPO clearance rate some evidence has in fact
recently been provided in humans that the halflife time ofEPO
in neonates (26) is shorter than that in adults (27, 28). On the
other hand, the fact that the increase in the ratio between
serum EPO levels and EPO mRNA coincides with the shifting
ofEPO gene expression from liver to kidneys, raises the ques-
tion whether the translational efficiency in the liver is less than
that in the kidneys, or whether a proportion of the newly syn-
thesized hormone in the liver cannot enter the systemic circula-
tion, since the liver is probably a major site ofEPO clearance.
Interestingly in this regard, no EPO was detected by Fried et al.
(29) or Caro et al. (25) by bioassay for EPO in liver extracts of
hypoxic newborn and developing rats; and Clemons et al., us-
ing a radioimmunoassay, found less EPO in the liver than in
the kidneys ofhypoxic rats as early as two days after birth (24).
Furthermore, although the age dependence ofthe effect ofbilat-
eral nephrectomy on EPO formation shown by others (2, 5, 6,
10) is completely in accordance with the shift of EPO mRNA
accumulation as observed in this study, a putative discrepancy
appears to arise with regard to the quantitative contribution of
the liver; while we found more than 30% of total EPO mRNA
in the livers of adult rats (Fig. 4, Table III), several studies
showed that serum EPO levels after bilateral nephrectomy are
reduced to - 10-15% (1-3, 30). To further investigate the
cause of this difference we measured EPO mRNA accumula-
tion in the livers in a separate group of bilaterally nephrecto-
mized rats.
Interestingly, as shown in Fig. 5, the amount of hepatic
EPO mRNA in the nephrectomized animals was significantly
reduced to - 55%. This suggests that, due to an inhibition of
EPO gene expression in the liver, studies in nephrectomized
animals may have underestimated the contribution ofthe liver
to EPO formation. Furthermore, since serum EPO levels after
nephrectomy were only slightly more reduced than the total
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amount of EPO mRNA, it appears unlikely that the relation-
ship between EPO mRNA and effective EPO production rate
in the liver is generally much lower than in the kidneys. Thus
the disproportionality between EPO mRNA and serum EPO
levels during development is probably not primarily due to a
switch in the site of production.
In conclusion, this study shows that: (a) despite a markedly
increasing responsiveness of developing rats in terms ofserum
EPO levels under hypoxia, the amount ofEPO mRNA, when
related to body weight, is rather constant or even decreasing
during development; (b) the liver contributes more than 50% to
the total amount of EPO mRNA for up to four weeks of life;
and (c) in adult animals the contribution of the liver under
strong stimulation is more significant than previously recog-
nized.
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